Clonidine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Clonidine and local guidelines before prescribing.
Mechanism
Central alpha-2 agonist.
Uses
Resistant hypertension, opioid withdrawal symptoms, migraine prophylaxis, ADHD, vasomotor symptoms.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Dry mouth, drowsiness, bradycardia, rebound hypertension on stopping.
Interactions
Beta-blockers increase rebound; tricyclics antagonise.
Contraindications and cautions
Bradycardia, depression
Monitoring
BP, pulse
Pregnancy and breastfeeding
Avoid unless essential
Renal and hepatic impairment
Reduce dose in renal impairment
Overdose and reversal
Supportive; atropine
Special advice
Withdraw slowly over days; stop beta-blocker first when stopping both.
More from the textbook: uses, cautions and other points
- Venlafaxine / citalopram / gabapentin / clonidine | Non-hormonal flush treatment; avoid fluoxetine/paroxetine with tamoxifen.
Gynaecology: Fertility Contraception Menopause - Drugs for disabling tics: aripiprazole , clonidine or guanfacine (also helps ADHD), risperidone.
Neurology: Movement Disorders - Aripiprazole / clonidine | Disabling tics in Tourette syndrome.
Neurology: Movement Disorders - Tourette syndrome - multiple motor tics and at least one vocal tic for over a year, starting before 18; associated with ADHD, OCD and anxiety. Education, behavioural therapy (habit reversal, CBIT); medication (aripiprazole, clonidine) if severe.
Paediatrics: Neurology, bones and joints in children - Taper drugs that cause withdrawal or rebound - benzodiazepines , antidepressants, antipsychotics, beta-blockers, steroids, gabapentinoids, opioids, PPIs (rebound acid), clonidine.
Medicine of the older adult: .Prescribing and deprescribing in older people - Up-regulation with chronic antagonist use → rebound on stopping (e.g. beta-blocker withdrawal - angina, tachycardia; clonidine - rebound hypertension).
Clinical pharmacology and prescribing: Principles of clinical pharmacology - Beta-blockers - rebound tachycardia and angina; clonidine - rebound hypertension.
Clinical pharmacology and prescribing: Principles of clinical pharmacology - Pupils - small (opioids, organophosphates, clonidine, some antipsychotics); large (anticholinergics, sympathomimetics, serotonergic drugs, withdrawal).
Clinical pharmacology and prescribing: Poisoning and overdose
Where it is discussed in the book
- Neurology: Movement Disorders (2 mentions)
- Paediatrics: Neurology, bones and joints in children (1 mention)
- Gynaecology: Fertility Contraception Menopause (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (2 mentions)
- Critical care: Admission and organ support (1 mention)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (1 mention)
- Integrated paediatrics chapter (1 mention)
- General Practice: Child health, women's health and men's health in primary care (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)